ROBIN SHERRINGTON

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ROBIN SHERRINGTON's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
46.28
Quantity 7,137
Value US$330,288
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-12 2024-06-12
PrS Proposed sale
85,856
456.68
US$894,727 		85,856 456.68 US$894,727
2024-03-08 2024-03-07
S Sale
37,717 +34.3%
201.76
US$4,261,115 		37,717 +34.3% 201.76 US$4,261,115
2024-03-08 2024-03-07
S Sale
18,645 -8.3%
304.51
US$2,875,591 		18,645 -8.3% 304.51 US$2,875,591
2024-03-07 2024-03-07
PrS Proposed sale
7,137
46.28
US$330,288 		7,137 46.28 US$330,288
2022-09-02 2022-09-01
S Sale
8,776 -34.3%
38.80
US$340,509 		8,776 -34.3% 38.80 US$340,509
2022-09-02 2022-09-01
S Sale
35,103 -57.9%
38.03
US$1,334,967 		35,103 -57.9% 38.03 US$1,334,967
2022-09-02 2022-08-31
S Sale
21,352 -56.0%
38.57
US$823,547 		21,352 -56.0% 38.57 US$823,547
2022-03-08 2022-03-04
S Sale
5,000 -22.5%
30.23
US$151,150 		5,000 -22.5% 30.23 US$151,150
2022-03-08 2022-03-04
S Sale
5,000 -18.4%
31.05
US$155,250 		5,000 -18.4% 31.05 US$155,250
2022-03-08 2022-03-04
S Sale
5,000 -15.5%
30.15
US$150,750 		5,000 -15.5% 30.15 US$150,750
2022-03-08 2022-03-04
S Sale
6,710 -17.2%
30.56
US$205,058 		6,710 -17.2% 30.56 US$205,058
2021-06-01 2021-05-28
S Sale
2,912 -8.3%
18.81
US$54,775 		2,912 -8.3% 18.81 US$54,775
2021-06-01 2021-05-28
S Sale
3,155 -8.2%
18.81
US$59,346 		3,155 -8.2% 18.81 US$59,346